{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By REUTERS", "person": [], "organization": "REUTERS"}, "abstract": null, "type_of_material": "News", "word_count": "27", "lead_paragraph": "The embattled $40 billion pharmaceuticals company tried \u2013 but failed \u2013 to quell concerns about its convoluted dealings with distributors.", "pub_date": "2015-10-27T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Video: Valeant Effort", "content_kicker": "Breakingviews"}, "snippet": "The embattled $40 billion pharmaceuticals company tried \u2013 but failed \u2013 to quell concerns about its convoluted dealings with distributors.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/10/27/business/dealbook/video-valeant-effort.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "2", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "blog": [], "_id": "562e664338f0d82f94187bfe", "source": "The New York Times"}